Luz Maria Alliende

Luz Maria Alliende

Auto-generated profile, based on publicly available information

Luz Maria Alliende

Department of Psychology, Northwestern University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
AZAndré Zugman
André Zugman
LALuz María Alliende
Luz María Alliende
VMVicente Medel
Vicente Medel
RBRichard Bethlehem
Richard Bethlehem
JSJakob Seidlitz
Jakob Seidlitz
NVNilakshi Vaidya
Nilakshi Vaidya
Gender inequality across the world has been associated with a higher risk to mental health problems and lower academic achievement in women compared to men. We also know that the brain is shaped by nurturing and adverse socio-environmental experiences. Therefore, unequal exposure to harsher conditions for women compared to men in gender-unequal countries might be reflected in differences in their brain structure, and this could be the neural mechanism partly explaining women’s worse outcomes in gender-unequal countries. We examined this through a random-effects meta-analysis on cortical thickness and surface area differences between adult healthy men and women, including a meta-regression in which country-level gender inequality acted as an explanatory variable for the observed differences. A total of 139 samples from 29 different countries, totaling 7,876 MRI scans, were included. Thickness of the right hemisphere, and particularly the right caudal anterior cingulate, right medial orbitofrontal, and left lateral occipital cortex, presented no differences or even thicker regional cortices in women compared to men in gender-equal countries, reversing to thinner cortices in countries with greater gender inequality. These results point to the potentially hazardous effect of gender inequality on women’s brains and provide initial evidence for neuroscience-informed policies for gender equality.

25 August 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
OPOrestis Papaioannou
Orestis Papaioannou
LCLaura P. Crespo
Laura P. Crespo
KCKailey Clark
Kailey Clark
NONicole N. Ogbuagu
Nicole N. Ogbuagu
LALuz Maria Alliende
Luz Maria Alliende
MEMolly Erickson
Molly Erickson
One of the proposed neural mechanisms involved in working memory is coupling between the theta phase and gamma amplitude. For example, evidence from intracranial recordings shows that coupling between hippocampal theta and cortical gamma oscillations increases selectively during working memory tasks. Theta-gamma phase-amplitude coupling can also be measured non-invasively through scalp EEG; however, EEG can only assess coupling within cortical areas, and it is not yet clear if this cortical-only coupling is truly memory-specific, or a more general phenomenon. We tested this directly by measuring cortical coupling during three different conditions: a working memory task, an attention task, and a passive perception condition. We find similar levels of theta-gamma coupling in all three conditions, suggesting that cortical theta-gamma phase-amplitude coupling is not a memory-specific signal, but instead reflects some other attentional or perceptual processes. Implications for understanding the brain dynamics of visual working memory are discussed.

15 May 2024 in Schizophrenia Research
Verified
Journal Article
Closed access
LALuz Maria Alliende
Luz Maria Alliende
GSGregory P. Strauss
Gregory P. Strauss
LYLawrence H. Yang
Lawrence H. Yang
VMVijay Anand Mittal
Vijay Anand Mittal

25 June 2024 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
LALuz Maria Alliende
Luz Maria Alliende
BSBeckett Ryden Sands
Beckett Ryden Sands
VMVijay Anand Mittal
Vijay Anand Mittal
Mental health stigma is prevalent and detrimental to the outcomes of people living with psychiatric diagnoses. These negative views may be at their most severe when it comes to people with schizophrenia (PSZ).1,2 One new avenue where stigmatization towards PSZ might be present is the burgeoning field of generative artificial intelligence (GAI). GAI is trained to the point of being capable of producing content, usually in response to prompts, based on the patterns present in the training material. GAI has been widely adopted in the past years and has become increasingly influential in clinical and academic psychaitry3 and lay users. Chatbot GAIs allow users to give written prompts, which lead models to generate answers that users can then build on as if having a conversation. The way chatbots can do this is by learning statistical relationships present in language,4 which they can do through training with an extensive corpus of written material. Proprietary chatbots, usually do not disclose the source or nature of these training materials, which makes it hard to assess the level of built-in stigma towards PSZ that could be present at this stage. Intentional checks and balances can be added in addition to the unsupervised training process to do things like ensure accuracy or restrict or qualify answers so that they meet what the model’s owners determine to be proper use. The manner in which proprietary models are modified after unsupervised training is also opaque. It is also ever-changing considering new assessments of risks, hazards, benefits, and user feedback.5

1 August 2023 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
LALuz Maria Alliende
Luz Maria Alliende
TVTeresa Vargas
Teresa Vargas
VMVijay Anand Mittal
Vijay Anand Mittal
Psychological science has worked under the assumption that White and middle or upper-class samples are neutral and generalizable, when they only represent a narrow slice of the global population.1–4 Current big data clinical datasets are also subject to this bias, even when their sheer size can make us assume generalizability. This editorial will discuss issues that can come along with (1) overconfidence and interpretability issues in large clinical databases, (2) lack of demographic data reporting, and (3) diversity and range restrictions. These limitations are particularly relevant for schizophrenia research where people living in relative poverty and ethnic minorities are disproportionately affected by the disorder.5,6 We will also discuss barriers contributing to these problems. The finals section of this editorial will propose some possible solutions.

16 July 2025 in European Psychiatry
Verified
Journal Article
Open access
PDF file
VMVicente Medel
Vicente Medel
LALuz M. Alliende
Luz M. Alliende
RBRichard Bethlehem
Richard Bethlehem
JSJakob Seidlitz
Jakob Seidlitz
GRGrace Ringlein
Grace Ringlein
NCNicolas A. Crossley
Nicolas A. Crossley
Background: The macro-social and environmental conditions in which people live, such as the level of a country’s development or inequality, are associated with brain-related disorders. However, the relationship between these systemic environmental factors and the brain remains unclear. We aimed to determine the association between the level of development and inequality of a country and the brain structure of healthy adults. Methods: We conducted a cross-sectional study pooling brain imaging (T1-based) data from 145 magnetic resonance imaging (MRI) studies in 7,962 healthy adults (4,110 women) in 29 different countries. We used a meta-regression approach to relate the brain structure to the country’s level of development and inequality. Results: Higher human development was consistently associated with larger hippocampi and more expanded global cortical surface area, particularly in frontal areas. Increased inequality was most consistently associated with smaller hippocampal volume and thinner cortical thickness across the brain. Conclusions: Our results suggest that the macro-economic conditions of a country are reflected in its inhabitants’ brains and may explain the different incidence of brain disorders across the world. The observed variability of brain structure in health across countries should be considered when developing tools in the field of personalized or precision medicine that are intended to be used across the world.